Silony Medical takes over Centinel Spine’s global fusion business

Silony Medical International AG, positioning itself as a formidable contender against established medtech giants in the spinal fusion domain, has concluded the acquisition of Centinel Spine’s Global Fusion Business. This move integrates Silony’s acclaimed Verticale posterior screw & rod fusion platform, its Roccia and Favo Interbody Fusion Systems, with Centinel’s renowned STALIF Technology Platform. The merger ushers in a pioneering spinal fusion portfolio, spanning from occiput to sacrum and catering to both open and minimally invasive spinal fusion procedures.

Strengthening Foothold in North America: Silony’s Strategic Vision

Having ventured into the US market in 2018, Silony seeks to leverage the established distribution network and skilled team from Centinel’s Fusion Portfolio. This strategic move aims to fortify Silony’s standing in the North American Spine Market, offering surgeons and medical teams unparalleled spine fusion solutions marked by versatility and autonomy.

“In the coming days and months, Silony will change its name to Silony Spine to underscore its 100% commitment & focus on spine fusion technology solutions,” the company spokesperson noted, hinting at a larger vision. Plans are also in motion to rejuvenate the STALIF Platform, promoting its wider acceptance among the spine surgeon fraternity. This will soon be followed by the unveiling of a new generation of tech-advanced instruments.

Deal Background: Centinel Spine’s Strategic Divestment

September 2023 witnessed Centinel Spine, a global lumbar and cervical spinal disease solutions provider known for its prodisc TDR technology platform, declaring its intention to sell its global Spine Fusion product suite and associated assets to Silony Medical, headquartered in Frauenfeld, Switzerland.

This divestiture allows Centinel Spine to channel its resources toward its burgeoning prodisc TDR enterprise, with aspirations of clinching the top spot as the global frontrunner in lumbar and cervical total disc replacement. Included in this transaction is Centinel Spine’s lumbar and cervical fusion suite—highlighted by the STALIF technology platform, which boasts an impressive clinical track record spanning over three decades with more than 100,000 devices implanted. The finalized deal’s specifics remain undisclosed, but it was projected to be sealed within a 45-day window.